MEDSCI (02415) Shareholder Transfers HK$88.21 Million Worth of Stocks from Merrill Lynch Far East Limited to CICC Hong Kong Securities

Stock News

Jan 08

The latest data from the Hong Kong Stock Exchange reveals that on January 7, a shareholder of MEDSCI (02415) transferred shares from Merrill Lynch Far East Limited to China International Capital Corporation Hong Kong Securities. The transferred shares had a market value of HK$88.2108 million, representing 10.53% of the company's stock. The company's previously released interim results for 2025 showed revenue of RMB 125 million, a year-on-year increase of 13.2%. Net profit reached RMB 13.239 million, surging by an impressive 5238.3% compared to the same period last year. Basic earnings per share were RMB 2.45 cents, and the company proposed an interim dividend of HK 1.1 cent per share. The increase in total revenue during the period was primarily driven by a recovery in the pharmaceutical industry and the accelerated transition of domestic pharmaceutical companies towards evidence-driven marketing models, which fueled demand for precision omnichannel marketing solutions.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1122730245"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1122730245\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1122730245?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-08 08:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1122730245","market":"sh","top_or_hot":-1,"title":"MEDSCI (02415) Shareholder Transfers HK$88.21 Million Worth of Stocks from Merrill Lynch Far East Limited to CICC Hong Kong Securities","media":"Stock News","content":"<p>The latest data from the Hong Kong Stock Exchange reveals that on January 7, a shareholder of MEDSCI (02415) transferred shares from Merrill Lynch Far East Limited to China International Capital Corporation Hong Kong Securities.\nThe transferred shares had a market value of HK$88.2108 million, representing 10.53% of the company's stock.\nThe company's previously released interim results for 2025 showed revenue of RMB 125 million, a year-on-year increase of 13.2%.\nNet profit reached RMB 13.239 million, surging by an impressive 5238.3% compared to the same period last year.\nBasic earnings per share were RMB 2.45 cents, and the company proposed an interim dividend of HK 1.1 cent per share.\nThe increase in total revenue during the period was primarily driven by a recovery in the pharmaceutical industry and the accelerated transition of domestic pharmaceutical companies towards evidence-driven marketing models, which fueled demand for precision omnichannel marketing solutions.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MEDSCI (02415) Shareholder Transfers HK$88.21 Million Worth of Stocks from Merrill Lynch Far East Limited to CICC Hong Kong Securities</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMEDSCI (02415) Shareholder Transfers HK$88.21 Million Worth of Stocks from Merrill Lynch Far East Limited to CICC Hong Kong Securities\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-01-08 08:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>The latest data from the Hong Kong Stock Exchange reveals that on January 7, a shareholder of MEDSCI (02415) transferred shares from Merrill Lynch Far East Limited to China International Capital Corporation Hong Kong Securities.\nThe transferred shares had a market value of HK$88.2108 million, representing 10.53% of the company's stock.\nThe company's previously released interim results for 2025 showed revenue of RMB 125 million, a year-on-year increase of 13.2%.\nNet profit reached RMB 13.239 million, surging by an impressive 5238.3% compared to the same period last year.\nBasic earnings per share were RMB 2.45 cents, and the company proposed an interim dividend of HK 1.1 cent per share.\nThe increase in total revenue during the period was primarily driven by a recovery in the pharmaceutical industry and the accelerated transition of domestic pharmaceutical companies towards evidence-driven marketing models, which fueled demand for precision omnichannel marketing solutions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1189","symbol_name":"医疗保健技术","start_time":0,"source_url":"","article_id":"1122730245","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1122730245","pubTimestamp":1767832218,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"The latest data from the Hong Kong Stock Exchange reveals that on January 7, a shareholder of MEDSCI (02415) transferred shares from Merrill Lynch Far East Limited to China International Capital...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"161027":"证券","BK1189":"医疗保健技术","02415":"梅斯健康"},"translate_title":"MEDSCI(02415)股东将Merrill Lynch Far East Limited价值8821万港元股票转让给中金香港证券","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"161027":1,"02415":1},"content_text":"The latest data from the Hong Kong Stock Exchange reveals that on January 7, a shareholder of MEDSCI (02415) transferred shares from Merrill Lynch Far East Limited to China International Capital Corporation Hong Kong Securities.\nThe transferred shares had a market value of HK$88.2108 million, representing 10.53% of the company's stock.\nThe company's previously released interim results for 2025 showed revenue of RMB 125 million, a year-on-year increase of 13.2%.\nNet profit reached RMB 13.239 million, surging by an impressive 5238.3% compared to the same period last year.\nBasic earnings per share were RMB 2.45 cents, and the company proposed an interim dividend of HK 1.1 cent per share.\nThe increase in total revenue during the period was primarily driven by a recovery in the pharmaceutical industry and the accelerated transition of domestic pharmaceutical companies towards evidence-driven marketing models, which fueled demand for precision omnichannel marketing solutions.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}